DNA ANALYSIS/AUTO SEQUENCING AND PHOSPHORIMAGING

$174,507P30FY2009CANIH

Duke University, Durham NC

Investigators

Linked publications, trials & patents

Paper 39605338 Paper 39416087 Paper 39320053 Paper 39307527 Paper 39253977 Paper 39238136 Paper 39227594 Paper 39176091 Paper 39146842 Paper 39133651 Paper 39083560 Paper 39075068 Paper 39034366 Paper 39014162 Paper 38976158 Paper 38935899 Paper 38886328 Paper 38886323 Paper 38871555 Paper 38860607 Paper 38826146 Paper 38798534 Paper 38788720 Paper 38771177 Paper 38769385 Paper 38759331 Paper 38742743 Paper 38670986 Paper 38650010 Paper 38623754 Paper 38607917 Paper 38569609 Paper 38519039 Paper 38438700 Paper 38380561 Paper 38359680 Paper 38350748 Paper 38325549 Paper 38272925 Paper 38260522 Paper 38260227 Paper 38242440 Paper 38236581 Paper 38226619 Paper 38106038 Paper 38104870 Paper 38104127 Paper 37985794 Paper 37985571 Paper 37922879 Paper 37909039 Paper 37890720 Paper 37884120 Paper 37857141 Paper 37827871 Paper 37772998 Paper 37760589 Paper 37737622 Paper 37697042 Paper 37696029 Paper 37671594 Paper 37655425 Paper 37619838 Paper 37595184 Paper 37588752 Paper 37575220 Paper 37556556 Paper 37543556 Paper 37523502 Paper 37466869 Paper 37460738 Paper 37442696 Paper 37436874 Paper 37350479 Paper 37315312 Paper 37311534 Paper 37307512 Paper 37306774 Paper 37188803 Paper 37182536 Paper 37173865 Paper 37149546 Paper 37009691 Paper 36966348 Paper 36944149 Trial NCT06529120 Trial NCT04576091 Trial NCT02154399 Trial NCT01284010 Trial NCT00890032 Trial NCT00811655 Trial NCT00742625 Trial NCT00626483 Trial NCT00470054 Trial NCT00337194 Trial NCT00118235 Trial NCT00110214 Trial NCT00098670 Trial NCT00086827 Patent 8399434

Abstract

DNA ANALYSIS SHARED RESOURCE Thomas Tedder, Ph.D., Director The Duke Comprehensive Cancer Center DNA Analysis Shared Resource consists of two related facilities, the Phosphorimager Facility and the DNA Sequencing Facility. This resource serves an interdisciplinary group of investigators from the Cancer Center, Medical Center and University. These investigators come from both the basic and clinical science areas with a wide range of interests including cancer biology, basic molecular biology, signal transduction, mechanisms of development, cellular response to infection and human diseases such as cancer, immunodeficiency, arthritis and heart disease. The Phosphofimager Facility allows researchers to analyze a wide variety of DNA and protein samples using autoradiography, fluorescence, and chemifluorescence detection. This technology permits scientists to easily perform accurate signal detection quantitatively over several orders of magnitude along with reduced exposure times. The DNA Sequencing Facility provides automated DNA Sequencing, DNA fragment analysis and mutation detection for rapid analysis of gene structure and function. Together, these two facilities combine to offer an integrated approach to serving the DNA analysis needs of the Duke University community. In addition, research is expedited by providing significant time savings in the production of data by replacing older, inefficient, and costly manual methods with state-of-the art, automated procedures. This resource makes available new fluorescence based techniques that reduce our dependence on the use of radioactivity.

View original record on NIH RePORTER →